Antimicrobial resistance networks in England
Medicines in Compliance Aids Stability Tool
Information on stability for tablets and capsules to help create MCAs for patients. Find entries and then build and print lists specific to your MCA.
Treating urinary disorders while breastfeeding
21 March 2023Oxybutynin is preferred for urinary disorders during breastfeeding. Recommendations apply to full term and healthy infants only.
Accredited training for pharmacy staff within technical services
17 March 2023Pharmacy staff involved in the preparation of aseptically-prepared products should be suitably trained and accredited to assure a safe service
Children's medicines: resources to support answering questions
17 March 2023Suggested resources to help primary care healthcare professionals find information on medicines use in paediatrics
Palliative care: useful resources to support answering questions
16 March 2023Suggested resources to help primary care healthcare professionals find information to answer questions about medicines use in palliative care
Using amlodipine or MR felodipine for angina and hypertension
13 March 2023Guidance on choosing and switching between amlodipine and modified-release (MR) felodipine for angina and hypertension.
Managing the risks of using effervescent tablets in children
9 March 2023Careful use of effervescent or soluble tablets to deliver part tablet doses for children and neonates can minimise risks of toxicity or suboptimal therapy.
Understanding the falsified medicines directive
9 March 2023An overview of the changes to the requirements for medicines ‘safety features’ following the UK’s departure from the EU
SPS Mini Conference - Antimicrobial Stewardship (AMS) – unlocking the potential
7 March 2023A highly informative webinar for healthcare teams leading, supporting, and providing oversight of antimicrobial stewardship.
SPS Spotlight Monthly Digest
6 March 2023A slide deck summarising SPS outputs and resources. It should be distributed to relevant healthcare professionals and their teams.
Pharmacy Manual Checklist for Clinical Trials for ATIMPs
2 March 2023Pharmacy Manual content expectations for optimal site implementation of ATIMP Clinical Trials.
Accessing the CAR-T training passport for clinical pharmacists
28 February 2023Members of the Pan UK Pharmacy Working Group for ATMPs have collaborated with UK BMT (Bone Marrow Transplant) pharmacists to produce a CAR-T training passport
Vaccines and immunisation: resources for answering questions
24 February 2023Suggested resources to help primary care healthcare professionals find information to answer questions on vaccines and immunisation
Medication Safety Update
23 February 2023A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.
Choosing between available adalimumab products
22 February 2023Understand the adalimumab products that are available on contract to the NHS. Choose between them appropriately for organisations or individuals.
PGD Learning Events 2023
21 February 2023We are delighted to announce dates for our three 2023 PGD WebEx events.
PGD Session 3: Q&A
21 February 2023This session is a chance for those who attended sessions 1 or 2 to have their PGD related questions answered by the expert panel.
PGD Session 2
21 February 2023PGDs and medicines mechanisms – what’s new? An update session for those managing and using PGDs and other medicine mechanisms in practice
Rosie Furner
Specialist Pharmacist - Medicines Governance, Specialist Pharmacy Service
Emma Bryant
Specialist Pharmacist – Mental Health, Specialist Pharmacy Service
Kieran Reynolds
Chief Pharmaceutical Officer's Clinical Fellow, Specialist Pharmacy Service
Using folic acid with methotrexate in rheumatoid arthritis
20 February 2023Folic acid is used to reduce methotrexate associated adverse effects in people with rheumatoid arthritis. This page guides appropriate dosing.
MAOI to other antidepressants: switching in adults
17 February 2023Switching between or from a monoamine oxidase inhibitor (MAOI) is always a complex switch and you should follow specialist advice.
Moclobemide to other antidepressants: switching in adults
17 February 2023How to switch safely from moclobemide to other antidepressants. Seek specialist advice for complex switches.
Trazodone to other antidepressants: switching in adults
17 February 2023How to switch safely from trazodone to other antidepressants. Seek specialist advice for complex switches.
Vortioxetine to other antidepressants: switching in adults
17 February 2023How to switch safely from vortioxetine to other antidepressants. Seek specialist advice for complex switches.
SNRIs to other antidepressants: switching in adults
17 February 2023How to switch safely between serotonin and noradrenaline reuptake inhibitors (SNRIs) or to other antidepressants. Seek specialist advice for complex switches.
Agomelatine to other antidepressants: switching in adults
17 February 2023How to switch safely from agomelatine to other antidepressants. Seek specialist advice for complex switches.
Mirtazapine to other antidepressants: switching in adults
17 February 2023How to switch safely from mirtazapine to other antidepressants. Seek specialist advice for complex switches.
Choosing an antidepressant to switch a person to
17 February 2023Where a need to switch antidepressant is established, appraise the options to identify what's suitable for the person. For complex switches: consult an expert.
Establishing whether a person needs to switch their antidepressant
17 February 2023Prior response, side-effects, new contraindications, and current symptoms may make an antidepressant switch necessary. When it is, establish shared goals.
Monitoring a person during and after antidepressant switching
17 February 2023Review people at appropriate time points; advise on what to expect and report; and beware of the possibility of discontinuation and serotonin syndromes.
Planning and agreeing an antidepressant switching strategy
17 February 2023Where the need for an antidepressant switch is established and you've agreed with the individual what to switch to, you can then plan and implement the switch.
Tricyclics to other antidepressants: switching in adults
17 February 2023How to switch safely between tricyclic antidepressants (TCAs) to other antidepressants or another TCA. Seek specialist advice for complex switches.
SSRIs to other antidepressants: switching in adults
17 February 2023How to switch safely between selective serotonin reuptake inhibitors (SSRIs) or to other antidepressants. Seek specialist advice for complex switches.
SPS Webinar - Medication Safety Across The System a ‘challenge for all’ - Opioid Safety
15 February 2023Discussion of key current medication safety challenges within healthcare with a focus on opioids. We aim to inspire partnership working across the system.
Using contraception with enzyme-inducing medicines
13 February 2023Enzyme-inducing medicines reduce the effectiveness of certain contraceptives. Guidance on using contraception with these medicines is given.
SPS Webinar - Chronic liver disease in primary care: an on the couch conversation.
9 February 2023A practical webinar to help guide primary care pharmacy professionals on how to appropriately manage patients with chronic liver disease in the community.